Together, this work will further
our understanding of lung cancer biology and create insight toward the development of new approaches to diagnose and treat patients suffering from this disease.
However, with our increasing
understanding of lung cancer biology has come the advent of targeted therapies to combat this devastating disease.
«This is the first study to show that this visit can improve a patient's
understanding of lung cancer screening, allowing them to make a decision about participation that fits their values,» noted Dr. Mazzone.
Not exact matches
Following their recent discovery
of a protein pathway, Moffitt
Cancer Center researchers are one step closer to understanding how lung cancer cells metast
Cancer Center researchers are one step closer to
understanding how
lung cancer cells metast
cancer cells metastasize.
A team
of researchers, led by Ross Cagan, PhD, developed a multi-gene
lung cancer model in the fruit fly Drosophila to better
understand the mechanisms that promote tumors in NSCLC.
Now, through this work, we are beginning to
understand why some subsets
of lung cancer are so invasive.»
These therapies were born out
of a deep
understanding of the potent genetic drivers
of lung cancer, particularly in nonsmokers.
This same kind
of clustering is also found in
cancers with well -
understood etiologies, such as melanoma (UV light) and
lung cancer (smoking).
«We're just beginning to
understand the relevance
of airway field cancerization to
lung cancer detection and development
of treatment and prevention strategies,» Kadara said.
Although we know that chemicals in tobacco smoke cause mutations in
lung cells that lead to
lung cancers and ultraviolet light causes mutations in skin cells that lead to skin
cancers, we have remarkably little
understanding of the biological processes that cause the mutations which are responsible for the development
of most
cancers.
Their results will help diseased cells to be characterised more exactly compared to healthy cells — which will enable a better
understanding of cancer,
lung diseases and heart diseases to be developed.
«Advances in
lung cancer therapy require a greater
understanding of the molecular origins
of this deadly disease,» said last corresponding author Levantini, who is also a researcher at the Institute
of Biomedical Technologies at the Italian National Research Council (ITB - CNR).
This better
understanding of BCX's molecular mechanism could lead to dietary recommendations for patients undergoing chemotherapy for
lung cancer and for those who have survived, said Wang, who is also a professor at the Friedman School.
Their findings, published last week in the Proceedings
of the National Academy
of Sciences, may provide clues for
understanding how some forms
of human
lung cancer initiate and may also aid in the development
of tools for successful gene therapy
of lung diseases such as cystic fibrosis.
To better
understand how these normally helpful components
of the immune system are put to nefarious tasks in
cancer cells, Verma and his colleagues developed a new method
of inducing non-small-cell
lung cancer in mice.
The biological mechanisms by which toxins in tobacco smoke cause
lung cancer are complex and still not completely
understood, but carcinogens in tobacco smoke may not only act as genetic inducers but also act to promote progression
of the disease.6 7 As well as potentially reducing the risk
of cancer related morbidity and mortality, quitting smoking at diagnosis could reduce overall mortality, as smoking cessation reduces mortality from other diseases such as heart disease, stroke, and chronic obstructive airways disease.8 9
myPlan
Lung Cancer provides an easy to understand measure of the aggressiveness of an individual's lung can
Lung Cancer provides an easy to understand measure of the aggressiveness of an individual's lung c
Cancer provides an easy to
understand measure
of the aggressiveness
of an individual's
lung can
lung cancercancer.
To translate advances in our
understanding of molecular mechanisms
of oncogenesis and tumor progression into novel therapeutic strategies.With primary focus on
lung cancer, melanoma, and lymphoma / leukemia, we will use the strength
of in - depth molecular and phenotypic characterization
of tumor heterogeneity to identify new targets and translate those into new therapeutic opportunities.
Let me put these odds things about the future in a perspective you can
understand; the chances are that you will die
of heart disease,
cancer,
lung disease or dementia.